Equities researchers at William Blair reduced their Q1 2025 EPS estimates for shares of Penumbra in a research report issued ...

The consensus estimate for Cabaletta Bio’s current full-year earnings is ($2.34) per share. William Blair also issued estimates for Cabaletta Bio’s Q2 2025 earnings at ($0.73) EPS, Q3 2025 ...

CBOE), following the company's latest earnings report. CBOE Holdings reported an adjusted EPS of $2.10, falling short of both William Blair's estimate of $2.12 and the consensus estimate of $2.13.

In a report released today, Louie DiPalma from William Blair maintained a Buy rating on VSE (VSEC – Research Report). The company’s shares ...

Since the yoga-wear maker makes most of its products in countries targeted with outsize tariffs, William Blair says the ...

Waste Connections’ stock is expected to benefit from the company’s peer-leading margins and the possibility of increased estimates as it pursues its growth strategies. William Blair’s ...

The firm believes the company’s valuation remains attractive, with DocuSign trading at 16.9x the firm’s calendar 2026 free cash flow estimate. William Blair sees room for margin expansion in ...

William Blair analyst Ryan Merkel maintained a Hold rating on MSC Industrial (MSM – Research Report) today. The company’s shares opened today ...

On Friday, William Blair analysts remained bullish on AAON Inc (NASDAQ:AAON), maintaining their Outperform rating despite lowering their first-half 2025 earnings estimates. The revision reflects ...